Cannformatics

Cannformatics, an early-stage biotechnology company, has unveiled a groundbreaking advancement in the field of medical cannabis treatment for Autism Spectrum Disorder (ASD). Their recent publication in Nature's Scientific Reports highlights the use of Cannabis-Responsive (C-Res) biomarkers and...

As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space. Emmy Award-Winning TV Personality Joins Cannformatics' Advisory...

Cannformatics, an early-stage biotechnology startup focused on personalizing medical cannabis treatment through the identification and application of saliva-based Cannabis-Responsive biomarkers, announced that Emmy Award winning television personality, medical cannabis advocate and entrepreneur...